Tagworks Pharmaceuticals is developing a unique approach towards antibody-based imaging and therapy. Tagworks’ technology enables the actuation of tagged antibodies through selective chemical manipulation in vivo, improving the efficacy of established approaches such as Radioimmuno-imaging and –therapy and Antibody-Drug Conjugates.
Just published in Angewandte Chemie: ‘click-to-release’… more
Tagworks reports that the scope of its proprietary click-to-release reaction can be expanded from the cleavage of carbamates to ethers,…
Tagworks publishes convincing results of cancer therapy in mice in Nature Communications
In mouse models of ovarian and aggressive colon cancer, Tagworks Pharmaceuticals has demonstrated the potent antitumour effect of the company’s…
Tagworks featured in BioCentury
Tagworks is featured in a BioCentury article on the state of the art and clinical prospects of in vivo click…